
Health authorities are implementing a targeted vaccination initiative aimed at protecting one million teenagers and young adults against meningitis B infections. The programme will offer two free doses of the MenB vaccine through the National Health Service during summer, with eligibility extending to Year 13 pupils and individuals under 25 enrolling in university or residential further education for the first time this autumn.
Meningitis is an infection affecting the protective membranes surrounding the brain and spinal cord. While the condition can affect any age group, it occurs most frequently in babies, young children, teenagers, and young adults. Bacterial meningitis, though rarer than viral forms, poses greater severity and can progress to blood poisoning, sepsis, and brain involvement. Meningococcal disease caused by group B bacteria accounts for the majority of severe cases in the UK. Official data indicates that in 2024-2025, there were 378 cases of invasive meningococcal disease recorded.
Symptoms of meningitis develop rapidly and may include a non-blanching rash, sudden high fever, severe headache, neck stiffness, vomiting, diarrhea, joint and muscle pain, light sensitivity, cold extremities, seizures, confusion, and extreme fatigue. The infection spreads through close personal contact, respiratory droplets from coughs and sneezes, saliva exchange through kissing, and shared items such as vapes and drinks. Some individuals carry the bacteria without becoming ill but can transmit it to others. Invasive meningococcal disease typically peaks between October and November annually.
Multiple vaccines provide protection against meningitis causes. The MenB vaccine, now included in routine childhood immunisation for babies born after 1 July 2015, is recommended at eight weeks, twelve weeks, and one year of age. The MenACWY vaccine, targeting four bacterial groups, is offered to fourteen-year-olds. Additional vaccines protecting against potential complications include the six-in-one childhood vaccine, pneumococcal vaccine, and the MMRV vaccine. All vaccines are non-live and cannot cause meningitis.
Anyone experiencing meningitis or sepsis symptoms should seek immediate emergency medical attention, as early treatment can be life-saving. Antibiotic administration to close contacts remains the most effective method for preventing disease spread within communities.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI